AVNS
Avanos Medical Inc
$
11.170
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
11.445
Open
11.410
VWAP
11.20
Vol
572.63K
Mkt Cap
516.55M
Low
11.075
Amount
6.41M
EV/EBITDA(TTM)
5.11
Total Shares
45.90M
EV
550.07M
EV/OCF(TTM)
4.09
P/S(TTM)
0.79
Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Its segment includes Specialty Nutrition Systems and Pain Management and Recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which includes products such as MIC-KEY enteral feeding tubes and Corpak patient feeding solutions and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products used to treat chronic pain conditions.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
171.50M
-4.51%
0.260
-39.53%
167.50M
-1.7%
0.180
-50%
165.50M
-3.61%
0.150
-55.88%
Estimates Revision
The market is revising Downward the revenue expectations for Avanos Medical, Inc. (AVNS) for FY2025, with the revenue forecasts being adjusted by -0.22% over the past three months. During the same period, the stock price has changed by -9.41%.
Revenue Estimates for FY2025
Revise Downward
-0.22%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-12.82%
In Past 3 Month
Stock Price
Go Down
-9.41%
In Past 3 Month
2 Analyst Rating
25.34% Upside
Wall Street analysts forecast AVNS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVNS is 14.00 USD with a low forecast of 14.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
2 Hold
0 Sell
Hold
25.34% Upside
Current: 11.170
Low
14.00
Averages
14.00
High
14.00
25.34% Upside
Current: 11.170
Low
14.00
Averages
14.00
High
14.00
The End
See All Ratings
No Data
Valuation Metrics
The current forward P/E ratio for Avanos Medical Inc (AVNS.N) is 13.78, compared to its 5-year average forward P/E of 21.04. For a more detailed relative valuation and DCF analysis to assess Avanos Medical Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Fair
5Y Average PE
21.04
Current PE
13.78
Overvalued PE
31.74
Undervalued PE
10.34
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
11.33
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
17.00
Undervalued EV/EBITDA
5.66
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
1.70
Current PS
0.82
Overvalued PS
2.30
Undervalued PS
1.10
Financials
Annual
Quarterly
FY2025Q1
YoY :
+0.84%
167.50M
Total Revenue
FY2025Q1
YoY :
+17.65%
12.00M
Operating Profit
FY2025Q1
YoY :
+1220.00%
6.60M
Net Income after Tax
FY2025Q1
YoY :
-800.00%
0.14
EPS - Diluted
FY2025Q1
YoY :
-257.02%
19.00M
Free Cash Flow
FY2025Q1
YoY :
-6.06%
53.61
Gross Profit Margin - %
FY2025Q1
YoY :
+743.88%
16.54
FCF Margin - %
FY2025Q1
YoY :
+1213.33%
3.94
Net Margin - %
FY2025Q1
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
106.8K
USD
1
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
7.2K
Volume
1
6-9
Months
186.4K
Volume
2
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
1
30.9K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
106.8K
USD
1
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
AVNS News & Events
Events Timeline
2025-07-31 (ET)
2025-07-31
16:30:01
Avanos divests Hyaluronic Acid product line to Channel-Markers Medical
2025-06-09 (ET)
2025-06-09
07:16:00
Avanos appoints Gilmore as SVP, Chief Human Resources Officer
2025-05-06 (ET)
2025-05-06
07:17:34
Avanos sees FY25 adjusted EPS 75c-95c
Sign Up For More Events
Sign Up For More Events
News
9.5
07-24NewsfilterAvanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2025 Financial Results
5.0
06-09NewsfilterAvanos Medical, Inc. Welcomes Camille Chang Gilmore as Senior Vice President and Chief Human Resources Officer
9.5
04-28PRnewswireAvanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results
Sign Up For More News
People Also Watch
INN
Summit Hotel Properties Inc
5.220
USD
-0.76%
EDN
Empresa Distribuidora y Comercializadora Norte SA
28.520
USD
-0.83%
ESQ
Esquire Financial Holdings Inc
95.880
USD
-0.27%
JACK
Jack in the Box Inc
19.700
USD
-2.38%
CVLG
Covenant Logistics Group Inc
24.150
USD
-0.86%
CCO
Clear Channel Outdoor Holdings Inc
1.060
USD
-1.85%
NOAH
Noah Holdings Ltd
12.150
USD
-0.25%
ETD
Ethan Allen Interiors Inc
29.770
USD
+1.99%
CSIQ
Canadian Solar Inc
11.490
USD
-1.96%
SLQT
SelectQuote Inc
1.760
USD
-3.83%
FAQ
What is Avanos Medical Inc (AVNS) stock price today?
The current price of AVNS is 11.17 USD — it has decreased -4.28 % in the last trading day.
What is Avanos Medical Inc (AVNS)'s business?
What is the price predicton of AVNS Stock?
What is Avanos Medical Inc (AVNS)'s revenue for the last quarter?
What is Avanos Medical Inc (AVNS)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Avanos Medical Inc (AVNS)'s fundamentals?
How many employees does Avanos Medical Inc (AVNS). have?